• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患支气管肺发育不良的婴儿出现早期肾上腺功能不全的证据。

Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia.

作者信息

Watterberg K L, Scott S M

机构信息

Department of Pediatrics, Pennsylvania State University Children's Hospital, Milton S. Hershey Medical Center, Hershey 17033, USA.

出版信息

Pediatrics. 1995 Jan;95(1):120-5.

PMID:7770288
Abstract

OBJECTIVES

To test the cortisol response to adrenocorticotrophic hormone (ACTH) in a population of very low birth weight newborns at the end of the first week of life, and to evaluate the relationship of this response to the subsequent development of bronchopulmonary dysplasia and to the total length of oxygen dependence.

METHODS

Appropriate for gestational age newborns < 1500 g birth weight were enrolled prospectively. Response to ACTH stimulation was tested on days 5, 6, or 7. Baseline cortisol, stimulated cortisol, and magnitude of response were compared between babies who developed bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 28 days, and those who recovered without BPD.

RESULTS

In this population, the cortisol response to ATCH increased with increasing birth weight (P < .001). Using birth weight as a cofactor, analysis of variance showed that patients who developed BPD (n = 34, BW 974 +/- 192 g, mean +/- S.D.) had significantly reduced responses to ACTH at 5 to 7 days of age compared to those who recovered (n = 25, BW 1251 +/- 194 g), P = .006. Additionally, 84% of patients who recovered without BPD, but only 26% of BPD patients, achieved a prospectively defined positive cortisol response to ACTH (> or = 9 micrograms/dL; P < .005). Supplemental oxygen was discontinued at a younger postconceptional age in babies with a positive cortisol response to ACTH (P < .01) and fewer of those babies were on supplemental oxygen at 36-week postconceptional age (P < .01).

CONCLUSIONS

At the end of the first week of life, infants who subsequently developed BPD and prolonged oxygen dependence had significantly lower cortisol secretion in response to ACTH than infants who recovered without BPD. We speculate that these babies may be unable to secrete adequate amounts of cortisol in a setting of increased stress, leaving them vulnerable to continuing lung injury.

摘要

目的

检测出生体重极低的新生儿在出生后第一周结束时对促肾上腺皮质激素(ACTH)的皮质醇反应,并评估该反应与随后支气管肺发育不良的发生以及氧依赖总时长之间的关系。

方法

前瞻性纳入出生体重<1500g的适于胎龄新生儿。在出生后第5、6或7天检测对ACTH刺激的反应。比较发生支气管肺发育不良(定义为出生后28天仍需氧依赖)的婴儿与未发生支气管肺发育不良而康复的婴儿的基础皮质醇、刺激后皮质醇及反应幅度。

结果

在该人群中,对ATCH的皮质醇反应随出生体重增加而增强(P<.001)。以出生体重作为协变量,方差分析显示,与康复的婴儿(n=25,体重1251±194g)相比,发生支气管肺发育不良的患者(n=34,体重974±192g,均值±标准差)在5至7日龄时对ACTH的反应显著降低,P=.006。此外,未发生支气管肺发育不良而康复的患者中84%对ACTH获得了预先定义的阳性皮质醇反应(≥9μg/dL;P<.005),而支气管肺发育不良患者中这一比例仅为26%。对ACTH有阳性皮质醇反应的婴儿在矫正胎龄较小时停止吸氧(P<.01),且在矫正胎龄36周时接受吸氧的此类婴儿较少(P<.01)。

结论

在出生后第一周结束时,随后发生支气管肺发育不良和长期氧依赖的婴儿对ACTH刺激的皮质醇分泌显著低于未发生支气管肺发育不良而康复的婴儿。我们推测,这些婴儿在应激增加的情况下可能无法分泌足够量的皮质醇,从而使其易受持续肺损伤的影响。

相似文献

1
Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia.患支气管肺发育不良的婴儿出现早期肾上腺功能不全的证据。
Pediatrics. 1995 Jan;95(1):120-5.
2
Basal and post-ACTH cortisol levels in preterm infants following treatment with dexamethasone.地塞米松治疗后早产儿的基础皮质醇水平和促肾上腺皮质激素刺激后皮质醇水平。
Clin Invest Med. 1993 Feb;16(1):8-14.
3
Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.抗氧化营养素和脂质过氧化在呼吸窘迫综合征和支气管肺发育不良早产儿中的作用。
Am J Perinatol. 2003 Feb;20(2):97-107. doi: 10.1055/s-2003-38315.
4
Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.支气管肺发育不良中的呼吸爆发活动及地塞米松对其的影响
Pediatr Pulmonol. 2003 May;35(5):392-9. doi: 10.1002/ppul.10279.
5
Potential biochemical growth markers in premature infants.早产儿潜在的生化生长标志物。
Am J Perinatol. 1999;16(7):339-49. doi: 10.1055/s-2007-993882.
6
Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life.出生体重极低的新生儿在出生后第一周接受机械通气治疗时发生支气管肺发育不良的危险因素。
J Trop Pediatr. 2005 Dec;51(6):334-40. doi: 10.1093/tropej/fmi051. Epub 2005 May 31.
7
Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.美国国立卫生研究院支气管肺发育不良共识定义的验证
Pediatrics. 2005 Dec;116(6):1353-60. doi: 10.1542/peds.2005-0249.
8
Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.小于胎龄的极低出生体重儿出生后早期体重下降与死亡或支气管肺发育不良之间的关联
J Perinatol. 2007 Jun;27(6):359-64. doi: 10.1038/sj.jp.7211751. Epub 2007 Apr 19.
9
Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.发生支气管肺发育不良的婴儿的绒毛膜羊膜炎和早期肺部炎症。
Pediatrics. 1996 Feb;97(2):210-5.
10
Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants.支气管肺发育不良的严重程度与极低出生体重早产儿喂养时饱和度降低和生长迟缓的风险增加有关。
Pediatr Pulmonol. 2010 Feb;45(2):165-73. doi: 10.1002/ppul.21171.

引用本文的文献

1
Current and Emerging Therapies for Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants.预防和治疗早产儿支气管肺发育不良的现有及新出现的疗法
Paediatr Drugs. 2025 May 15. doi: 10.1007/s40272-025-00697-3.
2
Timing of hydrocortisone therapy in neonates with shock: a systematic review, meta-analysis, and clinical practice guideline.新生儿休克氢化可的松治疗的时机:系统评价、荟萃分析及临床实践指南
Front Pediatr. 2025 Mar 12;13:1491976. doi: 10.3389/fped.2025.1491976. eCollection 2025.
3
Prophylactic low-dose hydrocortisone in neonates born extremely preterm: current knowledge and future challenges.
极低出生体重早产儿预防性使用低剂量氢化可的松:当前认知与未来挑战
Pediatr Res. 2025 Jul;98(1):65-71. doi: 10.1038/s41390-024-03756-6. Epub 2024 Nov 26.
4
Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.皮质类固醇预防和治疗支气管肺发育不良:系统评价概述。
Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD013271. doi: 10.1002/14651858.CD013271.pub2.
5
Prophylactic early low-dose hydrocortisone and survival without bronchopulmonary dysplasia among extremely preterm infants born at 22-27 weeks' gestation.22-27 孕周极早产儿预防性应用早期小剂量氢化可的松对支气管肺发育不良生存的影响。
J Perinatol. 2024 Jul;44(7):947-952. doi: 10.1038/s41372-024-01923-5. Epub 2024 Mar 8.
6
Early, low-dose hydrocortisone and near-term brain connectivity in extremely preterm infants.极早早产儿早期低剂量氢化可的松与近期脑连接性
Pediatr Res. 2024 Mar;95(4):1028-1034. doi: 10.1038/s41390-023-02903-9. Epub 2023 Nov 29.
7
Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia.产后皮质类固醇在支气管肺发育不良治疗或预防中的作用。
Sisli Etfal Hastan Tip Bul. 2023 Jun 20;57(2):171-181. doi: 10.14744/SEMB.2023.80688. eCollection 2023.
8
The beneficial effect of prophylactic hydrocortisone treatment in extremely preterm infants improves upon adjustment of the baseline characteristics.预防性氢化可的松治疗对极早产儿有益的效果在调整基线特征后得到改善。
Pediatr Res. 2024 Jan;95(1):251-256. doi: 10.1038/s41390-023-02785-x. Epub 2023 Aug 31.
9
Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.全身皮质类固醇预防支气管肺发育不良的网状荟萃分析。
Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD013730. doi: 10.1002/14651858.CD013730.pub2.
10
Glucocorticoid signature of preterm infants developing bronchopulmonary dysplasia.早产儿发生支气管肺发育不良的糖皮质激素特征。
Pediatr Res. 2023 Nov;94(5):1804-1809. doi: 10.1038/s41390-023-02690-3. Epub 2023 Jun 24.